R.J. Forbes

Senior Director, Corporate Finance and Investment Banking at Eli Lilly & Company

Speaker

R. J. has worked for Eli Lilly the past 11 years and has experience in all Lilly therapeutic areas (Diabetes, Oncology, Immunology, Pain, and Neurodegeneration). The first two years were in the Lilly Corporate MBA leadership development program. Over the next five years R. J. worked in commercial forecasting for business development projects. The most recent four years have been in the Lilly corporate finance valuation group that supports corporate business development efforts.

R. J.’s publicly traded deal sheet highlights are: Prevail Therapeutics acquisition, Dermira acquisition, Akouos acquisition, Point Biopharma acquisition, Morphic Therapeutics acquisition, and Baqsimi divestiture. R. J. has also supported many other signed licensing, collaboration, and direct equity transactions.

Prior to business school, R. J. worked for ten years in the financial services sector most recently on the buy side for Stifel Financial. R. J. is a CFA Charterholder, is a licensed CPA in Indiana, and obtained an MBA with a concentration in finance and Master of Science in Accounting from the Indiana University Kelley School of Business. R. J. has completed an intensive valuation certification program at the Investment Banking Institute in Chicago and has taught corporate finance at Butler University.